Monocyte chemotactic protein-1 (MCP-1) modulation of ethanol self-administration
Monocyte chemotactic protein-1 (MCP-1) modulation of ethanol self-administration
批准号:
8527207
负责人:
John Valenta
金额:
$3.67万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2015-08-31
关键词:
AcuteAlcohol PhenotypeAlcohol consumptionAlcohol dependenceAlcoholismAlcoholsAnimal ModelAnimalsAreaBehaviorBrainBrain InjuriesChronicControl AnimalDataDependenceDevelopmentEnvironmentEthanolExposure toGenesGoalsHumanImmune systemInflammationInflammatory ResponseInfusion proceduresInjection of therapeutic agentKnockout MiceKnowledgeLaboratoriesLeadMeasuresMediatingMicrogliaModelingMolecular TargetMonitorMonocyte Chemoattractant Protein-1PhaseRattusRecruitment ActivityResearchResourcesRodentRodent ModelRoleSelf AdministrationSelf-AdministeredSeveritiesSignal TransductionSignaling MoleculeSiteSliceTestingTherapeuticTherapeutic InterventionTimeTrainingWorkaddictionalcohol effectalcohol exposurecytokinedrinkingdrinking behaviorinsightknockout genemonocyte chemoattractant protein 1 receptormouse modelnovelpreferenceproblem drinkerpublic health relevancereceptorresearch studyresponsevapor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alcoholism has profound effects on the immune system, including the immune system of the brain. There is evidence that alcoholism increases neuroimmune signaling and inflammation. Alcoholic human brains have increased amounts of neuroimmune signaling molecules, and increasing neuroimmune signaling leads to increased alcohol consumption in animals. There is a possibility that decreasing neuroimmune signaling will lead to decreased alcohol drinking. The proposed experiments will investigate the role of a particular neuroimmune signaling molecule, MCP-1, in an animal model of drinking behavior. We will increase or decrease the amount of MCP-1 signaling in the brain and measure the effect on drinking behavior. There are three phases of drinking behavior we will investigate. First, we will look at the acquisition of drinking behavior (i.e., an animal that has never drunk before will
be given increased or decreased amount of MCP-1 signaling and we will measure the ability of the animal to start drinking). Next, we will look at the escalation of drinking behavior (i.e., the
animal will increase its drinking over time, and we will increase or decrease the amount of MCP-1 signaling to see if it increases or decreases the amount of alcohol the animal drinks over time). Third, we will look at drinking behavior in an addicted animal (i.e., the rodent will become
dependent on alcohol, and then we will increase or decrease the amount of MCP-1 signaling and measure its effect on drinking). Novel aspects of the application include using MCP-1 injections to regulate chronic drinking behavior and using MCP-1 antagonists to regulate either acute or chronic drinking behavior. The mechanisms of addiction are mysterious. The research proposed in this application will provide critical new knowledge about a new area of research and will increase our understanding of addiction. By understanding how neuroimmune signaling can regulate drinking behavior, we can develop insights into the transition from healthy to unhealthy drinking behavior and we can develop new molecular targets for treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monocyte chemotactic protein-1 (MCP-1) modulation of ethanol self-administration
-
批准号:8731618
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2013
-
负责人:John Valenta
-
依托单位:
海外基金